Review Article Medical Education Nephrology Public Health
Effect of point-of-care ultrasound on time to diagnosis among cancer survivors

Effect of point-of-care ultrasound on time to diagnosis among cancer survivors

Authors

Lucas Zhang

Lucas Zhang

American University of Beirut Medical Center, United Arab Emirates

Karim Tanaka

Karim Tanaka

Singapore General Hospital, Germany

Ines Patel

Ines Patel

American University of Beirut Medical Center, Montenegro

Omar Volkov

Omar Volkov

King Fahad Medical City, Iraq

Corresponding
Clara Nasser

Clara Nasser

Toronto General Hospital, New Caledonia

Published

May 29, 2026

Paper ID

PAP-000098

Status

Published

DOI

10.65712/tmj.test000356

Effect of point-of-care ultrasound on time to diagnosis among cancer survivors

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of point-of-care ultrasound were small or single-centre. Methods: The primary outcome was time to diagnosis, assessed blind to allocation. Results: The adjusted odds ratio was 0.82 (95% CI 0.30 to 0.70). Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

Guidelines make only a weak recommendation on point-of-care ultrasound. time to diagnosis remains a leading cause of avoidable harm among cancer survivors.

The cost of time to diagnosis to health systems is substantial. time to diagnosis remains a leading cause of avoidable harm among cancer survivors.

Materials and Methods

The primary outcome was time to diagnosis, assessed blind to allocation. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

We conducted a quality-improvement audit across 8 centres between 2020 and 2021. We conducted a quality-improvement audit across 12 centres between 2018 and 2022.

We conducted a quality-improvement audit across 11 centres between 2019 and 2021. We conducted a quality-improvement audit across 3 centres between 2020 and 2022.

Results

The adjusted odds ratio was 0.91 (95% CI 0.40 to 0.82). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

time to diagnosis occurred in 5% of the intervention group versus 27% of controls. time to diagnosis occurred in 22% of the intervention group versus 25% of controls. Effects were consistent across prespecified subgroups.

GroupnEventsRate %
Centre A5378916.8
Centre A6781518.0
Centre B53787.9
Age < 6568910727.1
TABLE 1: Subgroup analysis
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in time to diagnosis
Shown for cancer survivors; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Distribution of time to diagnosis
Shown for cancer survivors; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.62 (95% CI 0.31 to 0.73). Effects were consistent across prespecified subgroups.

time to diagnosis occurred in 8% of the intervention group versus 28% of controls. Effects were consistent across prespecified subgroups.

Discussion

These findings suggest that point-of-care ultrasound is associated with better time to diagnosis in cancer survivors. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. Future work should test point-of-care ultrasound in a pragmatic multicentre trial. These findings suggest that point-of-care ultrasound is associated with better time to diagnosis in cancer survivors.

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.

Conclusions

Point-of-care ultrasound merits wider use for cancer survivors to improve time to diagnosis.

References

1. Mueller P, Schmidt S, et al. Vitamin D supplementation and falls. Ann Intern Med. 2009;19(12):847-1466.

2. Rossi Y, Kim T, et al. Nurse-led discharge planning and emergency department revisits. Ann Intern Med. 2010;357(3):772-1327.

3. Dubois T, Costa Z, et al. Home-based cardiac rehabilitation and ventilator-free days. Eur Heart J. 2018;280(12):809-1475.

4. Costa D, Novak D, et al. An antibiotic stewardship programme and chronic pain scores. Crit Care Med. 2008;320(2):726-1428.

5. Andersen N, Osei F, et al. Low-dose aspirin and post-operative delirium. N Engl J Med. 2022;353(9):347-1583.

6. Kaur I, Patel I, et al. Continuous glucose monitoring and in-hospital mortality. Diabetes Care. 2008;332(7):801-1324.

7. Ahmed C, Costa V, et al. Nurse-led discharge planning and health-related quality of life. N Engl J Med. 2022;393(10):611-1525.

8. Moreau B, Volkov M, et al. Continuous glucose monitoring and acute kidney injury. BMC Med. 2025;232(1):545-1171.

9. Nasser J, Ibrahim E, et al. High-flow nasal oxygen and length of stay. N Engl J Med. 2018;253(8):387-1320.

Appendices

The statistical analysis plan is in the online supplement.